The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $1.27 in the prior trading day, Ikena Oncology Inc (NASDAQ: IKNA) closed at $1.24, down -2.36%. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 1.28 million shares were traded. IKNA stock price reached its highest trading level at $1.2752 during the session, while it also had its lowest trading level at $1.2.
Ratios:
Our goal is to gain a better understanding of IKNA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.31 and its Current Ratio is at 13.31. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wedbush on May 29, 2024, Downgraded its rating to Neutral and sets its target price to $2 from $8 previously.
On September 22, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IKNA now has a Market Capitalization of 51942980 and an Enterprise Value of -42775132.
Stock Price History:
The Beta on a monthly basis for IKNA is 0.50, which has changed by -0.25748503 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, IKNA has reached a high of $1.94, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -3.61%, while the 200-Day Moving Average is calculated to be -13.94%.
Shares Statistics:
The stock has traded on average 167.20K shares per day over the past 3-months and 691190 shares per day over the last 10 days, according to various share statistics. A total of 48.26M shares are outstanding, with a floating share count of 20.95M. Insiders hold about 56.58% of the company’s shares, while institutions hold 33.21% stake in the company. Shares short for IKNA as of 1749772800 were 80668 with a Short Ratio of 0.54, compared to 1747267200 on 115649. Therefore, it implies a Short% of Shares Outstanding of 80668 and a Short% of Float of 0.19.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Ikena Oncology Inc (IKNA) is currently drawing attention from 1.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.51 and -$0.51 for the fiscal current year, implying an average EPS of -$0.51.
